HPV vaccine linked to population benefit
from MedPage Today
Despite "very low to moderate" uptake of the human papillomavirus vaccine, it is having a substantial impact in reducing one of HPV's most common symptoms, a researcher said here. Over the period the vaccine has been in use, starting in 2006, the annual prevalence of anogenital warts has fallen significantly among young women and adolescent girls, according to Elaine Flagg, Ph.D., of the CDC's division of STD prevention in Atlanta.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063